Continuous Glucose Monitoring System - NMPA Registration 国械注准20243072505
Access comprehensive regulatory information for Continuous Glucose Monitoring System in the China medical device market through Pure Global AI's free database. This Class III medical device is registered under NMPA registration number 国械注准20243072505 and owned by Sinocare Inc.. The device was approved on December 13, 2024.
This page provides complete registration details including registrant information, province location (Hunan), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
该产品配合持续葡萄糖监测系统应用程序(型号规格:iCGM-APP Pro、iCGM-APP;发布版本:02)、持续葡萄糖监测系统管理软件(发布版本:01)使用,可用于糖尿病成年患者(≥18岁)的组织液葡萄糖水平的连续或定期监测.该产品仅供单个用户在医疗机构使用,不需要用户校准,使用时间最长8天.该产品测量结果不作为决定和调整糖尿病患者治疗方案的依据.
该产品配合持续葡萄糖监测系统应用程序（型号规格：iCGM-APP Pro、iCGM-APP；发布版本：02）、持续葡萄糖监测系统管理软件（发布版本：01）使用，可用于糖尿病成年患者（≥18岁）的组织液葡萄糖水平的连续或定期监测。该产品仅供单个用户在医疗机构使用，不需要用户校准，使用时间最长8天。该产品测量结果不作为决定和调整糖尿病患者治疗方案的依据。
该产品由传感器套装(含探头)组成.
该产品由传感器套装(含探头)组成。